About the Product

Description


Risplom 4T MD Tablet containing Risperidone and Trihexyphenidyl is used in the management of psychiatric disorders and associated treatment-related movement symptoms. It helps support mental health and overall patient well-being under medical supervision.

Risperidone works as an atypical antipsychotic that helps regulate neurotransmitter activity in the brain, while Trihexyphenidyl acts as an anticholinergic agent that helps manage certain movement-related side effects associated with antipsychotic therapy.

The tablet is widely prescribed in psychiatric practice for the management of psychotic disorders and related conditions requiring combination therapy, leading to consistent prescription demand.

With increasing awareness of mental health and growing demand for effective psychiatric therapies, this product offers strong business potential for retailers and distributors. Its established clinical relevance, combination therapeutic benefits, and steady market demand make it a reliable product for growth in the neuro psychiatry segment.

Important Notice: Risperidone is a prescription medicine that should be used under qualified medical supervision. Distribution and marketing should comply with all applicable regulatory requirements.

Some patients may experience drowsiness, dizziness, dry mouth, constipation, blurred vision, weight gain, increased appetite, tremors, or fatigue. Rarely, severe movement disorders, neuroleptic malignant syndrome, elevated prolactin levels, cardiac rhythm abnormalities, or severe allergic reactions may occur and require immediate medical attention.

Risplom 4T MD Tablet is indicated for schizophrenia, psychotic disorders, bipolar disorder with psychotic features, and other psychiatric conditions as prescribed by a healthcare professional. It helps control symptoms such as hallucinations, delusions, disorganized thinking, agitation, and behavioral disturbances while minimizing movement-related side effects.

This medicine should be used strictly under medical supervision. Do not stop treatment abruptly without consulting a healthcare professional. Use cautiously in patients with cardiovascular disease, glaucoma, prostate enlargement, liver impairment, kidney disease, diabetes, or a history of seizures. Regular monitoring of weight, blood sugar, and overall clinical response may be recommended during therapy.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Risperidone 4mg + Trihexyphenidyl 2mg Tablet in the PCD pharma franchise market?

Risperidone 4mg + Trihexyphenidyl 2mg Tablet has strong demand in the psychiatry, mental health, and CNS (Central Nervous System) segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on neuropsychiatric care portfolios.

Why should medical distributors include Risperidone + Trihexyphenidyl Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for psychiatric disorder management under medical supervision. Risperidone 4mg is an atypical antipsychotic used in the management of various psychiatric disorders Trihexyphenidyl 2mg is an anticholinergic agent commonly used to help manage extrapyramidal symptoms associated with antipsychotic therapy Commonly prescribed for schizophrenia, psychotic disorders, and other psychiatric conditions as determined by healthcare professionals The combination supports effective psychiatric treatment while helping improve patient tolerability of therapy This strengthens a comprehensive CNS and mental healthcare portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Risperidone 4mg + Trihexyphenidyl 2mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from steady prescription demand in psychiatry practice, long-term therapy usage, repeat orders, reliable supply chain support, and attractive margins in the CNS segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.